Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | BMC Cancer

Fig. 4

From: Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients

Fig. 4

Oncomine analysis showing loss of Parkin (PARK-2) expression in different types of breast carcinoma in TCGA. a Invasive lobular breast carcinoma vs. normal tissues, b Invasive breast carcinoma vs. normal tissues, and c Invasive ductal breast carcinoma vs. normal tissues using TCGA breast data. d Relation of Parkin mRNA expression among different subgroups of breast cancer such as Normal, Luminal, Her2 Positive and Triple-negative breast cancers. Oncomine database (; TCGA: The Cancer Genome Atlas (Significant value: P < 0.05)

Back to article page